Stefánsson Einar, la Cour Morten, Helgadóttir Gudleif, Sigurdsson Haraldur, Jónasson Fridbert
Laeknalid Háskóla Islands.
Laeknabladid. 2007 Apr;93(4):299-301.
New drugs for age-related macular degeneration present a major advance in the treatment of the most common cause of blindness in Iceland. Vascular endothelial growth factor antibodies reduce the risk of blindness and improve vision in patients with age-related macular degeneration.
用于治疗年龄相关性黄斑变性的新药是冰岛治疗最常见致盲原因的一项重大进展。血管内皮生长因子抗体可降低年龄相关性黄斑变性患者的失明风险并改善视力。